Peak Human Labs Podcast

Dr.Sanjeev Goel MD and Carmelia Ray discuss the recent breakthrough medication, Leqembi, and its approval for submission to Health Canada. Additionally, we explore Eli Lilly's promising phase three trial results, which show potential in reversing or slowing down Alzheimer's progression. We delve into the concept of neurogenesis and a groundbreaking study that stimulates the growth of new brain cells to combat Alzheimer's. Furthermore, we examine the correlation between the Mediterranean diet and a lower risk of developing Alzheimer's, as revealed by a study involving over 60,000 participants. Join us as we share exciting discoveries and insights in the battle against Alzheimer's. Don't forget to subscribe, like, and share if you find this information valuable. Feel free to leave your questions in the comments, and we'll be glad to address them in future episodes. Together, let's work towards preventing and ending Alzheimer's.